The Risk of Therapy-Related Myelodysplasia/Acute Myeloid Leukemia in Hodgkin Lymphoma has Substantially Decreased in the ABVD Era Abolishing Mechlorethamine and Procarbazine and Limiting Volumes and Doses of Radiotherapy (Q34639390)
Jump to navigation
Jump to search
scientific article published on April 6, 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The Risk of Therapy-Related Myelodysplasia/Acute Myeloid Leukemia in Hodgkin Lymphoma has Substantially Decreased in the ABVD Era Abolishing Mechlorethamine and Procarbazine and Limiting Volumes and Doses of Radiotherapy |
scientific article published on April 6, 2012 |
Statements
1 reference
The Risk of Therapy-Related Myelodysplasia/Acute Myeloid Leukemia in Hodgkin Lymphoma has Substantially Decreased in the ABVD Era Abolishing Mechlorethamine and Procarbazine and Limiting Volumes and Doses of Radiotherapy (English)
1 reference
Ercole Brusamolino
1 reference
Manuel Gotti
1 reference
Valeria Fiaccadori
1 reference
6 April 2012
1 reference
1 reference
4
1 reference
1
1 reference
e2012022
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference